Home

Aspira Pathlab & Diagnostics Ltd PB Ratio

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

PB

3.5

Last updated on: 22 Nov 24

Key Highlights

  • The latest PB Ratio of Aspira Pathlab & Diagnostics Ltd is 3.5.
  • The PB ratio of the Aspira Pathlab & Diagnostics Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Aspira Pathlab & Diagnostics Ltd changed from 85.5 on March 2019 to 6.1 on March 2024 . This represents a CAGR of -35.60% over 6 years.

Historical P/B Ratio of Aspira Pathlab & Diagnostics Ltd

No data available

Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

Market Cap

67 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

3.5

Day’s High

67.51

Day’s Low

61.1

DTE

0.2

ROE

0.0

52 Week High

72.35

52 Week Low

25.0

ROCE

0.0

Market Price of Aspira Pathlab & Diagnostics Ltd

1M

1Y

3Y

5Y

Monitoring Aspira Pathlab & Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202466
21 Nov 202464.3
19 Nov 202467.68
18 Nov 202469.9
14 Nov 202466.58

SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Aspira Pathlab & Diagnostics Ltd

Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

Company
leftPBright
Aspira Pathlab & Diagnostics Ltd3.52
Apollo Hospitals Enterprise Ltd569.6
Max Healthcare Institute Ltd81.7
Fortis Healthcare Ltd120.2
Syngene International Ltd107.3

Historical Market Cap of Aspira Pathlab & Diagnostics Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aspira Pathlab & Diagnostics Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

FAQs for PB Ratio of Aspira Pathlab & Diagnostics Ltd

What is the PB ratio of Aspira Pathlab & Diagnostics Ltd?

The current PB ratio of Aspira Pathlab & Diagnostics Ltd is 3.52. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Aspira Pathlab & Diagnostics Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Aspira Pathlab & Diagnostics Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Aspira Pathlab & Diagnostics Ltd calculated?

The PB ratio of Aspira Pathlab & Diagnostics Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Aspira Pathlab & Diagnostics Ltd?

A high PB ratio suggests that Aspira Pathlab & Diagnostics Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Aspira Pathlab & Diagnostics Ltd?

A low PB ratio of Aspira Pathlab & Diagnostics Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Aspira Pathlab & Diagnostics Ltd PB Ratio change over time?

Yes, the PB ratio of Aspira Pathlab & Diagnostics Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*